Predilife S.A. (ALPRE.PA)

EUR 3.8

(0.53%)

EBITDA Summary of Predilife S.A.

  • Predilife S.A.'s latest annual EBITDA in 2023 was -3.82 Million EUR , down -9.5% from previous year.
  • Predilife S.A.'s latest quarterly EBITDA in 2023 FY was N/A , down -9.5% from previous quarter.
  • Predilife S.A. reported an annual EBITDA of -3.47 Million EUR in 2022, up 0.9% from previous year.
  • Predilife S.A. reported an annual EBITDA of -3.49 Million EUR in 2021, down -31.47% from previous year.
  • Predilife S.A. reported a quarterly EBITDA of -2.05 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • Predilife S.A. reported a quarterly EBITDA of -1.79 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of Predilife S.A. (2023 - 2016)

Historical Annual EBITDA of Predilife S.A. (2023 - 2016)

Year EBITDA EBITDA Growth
2023 -3.82 Million EUR -9.5%
2022 -3.47 Million EUR 0.9%
2021 -3.49 Million EUR -31.47%
2020 -2.46 Million EUR -12.19%
2019 -2.39 Million EUR -1.99%
2018 -2.51 Million EUR -24.99%
2017 -1.87 Million EUR -16.79%
2016 -1.6 Million EUR 0.0%

Peer EBITDA Comparison of Predilife S.A.

Name EBITDA EBITDA Difference
Biosynex SA -10.18 Million EUR 62.479%
bioMérieux S.A. 828.1 Million EUR 100.461%
Eurofins Scientific SE 1.2 Billion EUR 100.317%
Lumibird SA 27.3 Million EUR 113.992%